Ella runs on an AI infrastructure that meets the strict requirements of German and EU law without compromising on performance or speed, from a sovereign phone assistant to complex medication safety (AMTS) applications.
EU prospectus 2024 filed · new prospectus in preparation · discreet first contact
The shortage of skilled staff grows by the day, while the number of patients and very elderly people keeps rising. Demographic change is irreversible and here to stay. The task now is to use AI to provide the support that people alone can no longer give.
Doctors, nurses and midwives missing across the EU 1
Pharmacies plus doctor's and psychotherapy practices in Germany alone, our addressable market 2
Average annual growth of the European conversational AI market to 2030 3
Share of all calls to practices and pharmacies that a digital assistant can handle as routine, with no further action needed 4
¹ OECD / European Commission, Health at a Glance: Europe 2024 · ² ABDA 2024 · KBV physician statistics 2024 · ³ Grand View Research, Europe Conversational AI Outlook 2025 · ⁴ Ella pilot survey Q1/2026
Ella runs 100 % on EU servers. GDPR and the EU AI Act are built into the architecture, not added afterwards. For a health system that works with especially sensitive data, this is a prerequisite, not a nice-to-have.
With the Ella Box, we are bringing the first local AI hardware solution for pharmacies, practices and healthcare providers to market. The Ella Box ensures that especially sensitive data is used and processed only on site, within the local network.
We do not build smart answering machines. We support the whole of healthcare communication: from the first call to a doctor or pharmacist, through information and assistance systems during the medical history, to app-based follow-up care.
In use across three continents, in more than a dozen countries and in over 20 languages.
A pioneer in AI research since 2016. Active as a Swiss company since 2020. Present through our own companies in Germany, Luxembourg, the USA and Switzerland.
Optimal performance with maximum data security: that is the guiding principle of our product development.
How far our AI systems go is for our customers to decide. They configure their assistants themselves through an intuitive web application. They add compatible modules to the systems they already use. For large customers, we provide bespoke solutions.
The EU is already short of around 1.2 million doctors, nurses and midwives. According to the WHO, the gap in the WHO European Region could grow to around 4 million by 2030. One solution: technology takes on time-consuming routine communication.
The phone remains the most important channel in healthcare. The generations that will place the greatest demands on the health system as they age over the coming decades do not write emails or posts, they call. That makes phone assistants a key technology.
GDPR and the EU AI Act are hurdles for US providers, a home advantage for Ella. 100 % EU hosting, compliance by design.
Every conversation generates data that Ella uses in a regulation-compliant way to improve the way patients and their care providers work together.
Pharmacies and practices book Ella's digital assistants as a monthly subscription.
Guaranteed minimum revenue per customer: €140 per month
Distribution of Ella's solutions, including first-level support, through pharmacy and doctors' associations, software makers and hardware suppliers with long-established customer relationships.
Sales and first-level support through established partners
The Ella Box makes secure use of AI possible anywhere that sensitive data must be processed locally.
Guaranteed minimum revenue per customer: €400 per month
Ella starts where the urgency is greatest. But the platform is built for dynamic growth: into adjacent markets, because other languages are no barrier and almost every Western industrialised nation faces the same challenges in the healthcare sector.
Renowned clinic chains and pharmacy associations in several countries want to use Ella assistants. In Canada and Brazil, we have signed our first contracts with established distributors in the healthcare sector.
In the coming months, Ella will bring new, innovative services for pharmacies and doctors' practices to market: comprehensive, intelligent management of medication plans is in development, as are interactive post-anamnesis assistants.
For us, healthcare communication does not begin only when a patient falls ill: healthy sleep, healthy nutrition, mental stability, exercise. With further assistants, Ella creates a holistic well-being world for a healthy life in every respect.
Bricks-and-mortar retail is becoming a major new player in the health market. Medical and pharmacy services will find their way into supermarkets. Ella has secured key rights to this business and is developing it in exclusive partnership with the leading supermarket chains in the DACH region.
The key questions on participation certificates, subscription and tax matters. The information in the applicable securities prospectus is binding.
Write to us at investorrelations@ella-group.io. We will reply personally, talk through your questions and make all the documents and the current securities prospectus available to you discreetly.
In essence, participation certificates are “non-voting shares” issued in return for a contribution. Holders are entitled primarily to economic rights: a share in the balance sheet profit or dividend and in the distribution of any liquidation proceeds, as well as the right to subscribe for new shares.
You will find the terms and further information on the participation certificates in the current securities prospectus. For details, contact us directly at investorrelations@ella-group.io.
Beyond the purchase price of the participation certificates, the issuer charges investors no administrative costs. Please note that the purchase price is payable in euros.
Ella is pursuing an ambitious growth story. Projects that can be financed from the earnings of ongoing operations are delivered faster with additional capital. Capital is the accelerator in our development.
The board of directors enters the holders and the number of participation certificates each one holds in a company register kept for this purpose.
As a rule, the Board of Directors allots the participation certificates within one to two months of subscription. You receive a corresponding written confirmation of the entry.
Income tax is governed by the tax law of each investor's country of residence. We recommend seeking personalised tax advice.
All mandatory publications of our three completed public offerings under the EU Prospectus Regulation are permanently and publicly accessible here.
Notices (13)
Notices (13)
The documents are subject to the EU Prospectus Regulation and remain publicly accessible in accordance with the statutory retention obligation. If you have any questions, please contact investorrelations@ella-group.io.
The driving force behind Ella.
Founder · CEO · Board Member
Michael Keusgen has been at the helm of Ella since the research initiative in 2016. He has led the company since Ella Media AG was formally founded in 2020. His aim: technology that creates and develops relationships between people rather than replacing them.
With almost four decades of experience in technology and media, he has developed Ella from a research idea into a regulation-compliant AI platform for European healthcare, today with a team of around 20 people across three locations.
The latest in artificial intelligence, and in the health sector in particular, is something we put into context regularly and expertly in our podcast. An exclusive service for our investors. Ten minutes that are also time well invested.
Get in touch with us about investing, discreetly, without obligation, with all the relevant key figures.
